Huber Y Labenz C Michel M Wrns M
Huber, Y; Labenz, C; Michel, M; Wörns, M; Galle, P R; Kostev, K; Schattenberg, J M Tumor Incidence in Patients with Non-Alcoholic Fatty Liver Disease Dtsch Arztebl Int 2020; 117(43): 719 -24; DOI: 10. 3238/arztebl. 2020. 0719
Huber, Y; Labenz, C; Michel, M; Wörns, M; Galle, P R; Kostev, K; Schattenberg, J M Tumor Incidence in Patients with Non-Alcoholic Fatty Liver Disease Dtsch Arztebl Int 2020; 117(43): 719 -24; DOI: 10. 3238/arztebl. 2020. 0719
Huber, Y; Labenz, C; Michel, M; Wörns, M; Galle, P R; Kostev, K; Schattenberg, J M Tumor Incidence in Patients with Non-Alcoholic Fatty Liver Disease Dtsch Arztebl Int 2020; 117(43): 719 -24; DOI: 10. 3238/arztebl. 2020. 0719
Huber, Y; Labenz, C; Michel, M; Wörns, M; Galle, P R; Kostev, K; Schattenberg, J M Tumor Incidence in Patients with Non-Alcoholic Fatty Liver Disease Dtsch Arztebl Int 2020; 117(43): 719 -24; DOI: 10. 3238/arztebl. 2020. 0719
Huber, Y; Labenz, C; Michel, M; Wörns, M; Galle, P R; Kostev, K; Schattenberg, J M Tumor Incidence in Patients with Non-Alcoholic Fatty Liver Disease Dtsch Arztebl Int 2020; 117(43): 719 -24; DOI: 10. 3238/arztebl. 2020. 0719
Huber, Y; Labenz, C; Michel, M; Wörns, M; Galle, P R; Kostev, K; Schattenberg, J M Tumor Incidence in Patients with Non-Alcoholic Fatty Liver Disease Dtsch Arztebl Int 2020; 117(43): 719 -24; DOI: 10. 3238/arztebl. 2020. 0719
Huber, Y; Labenz, C; Michel, M; Wörns, M; Galle, P R; Kostev, K; Schattenberg, J M Tumor Incidence in Patients with Non-Alcoholic Fatty Liver Disease Dtsch Arztebl Int 2020; 117(43): 719 -24; DOI: 10. 3238/arztebl. 2020. 0719
Huber, Y; Labenz, C; Michel, M; Wörns, M; Galle, P R; Kostev, K; Schattenberg, J M Tumor Incidence in Patients with Non-Alcoholic Fatty Liver Disease Dtsch Arztebl Int 2020; 117(43): 719 -24; DOI: 10. 3238/arztebl. 2020. 0719
- Slides: 8
